Advancing AML Treatment: Evidence-Based Regimens and Guideline Updates for Targeted Treatments in R/R AML [Podcast]
Zeidan A, Wang E. Advancing AML Treatment: Evidence-Based Regimens and Guideline Updates for Targeted Treatments in R/R AML [Podcast]. Blood And Lymphatic Cancer Targets And Therapy 2025, 15: 77-83. PMID: 40630561, PMCID: PMC12235439, DOI: 10.2147/blctt.s548242.Peer-Reviewed Original ResearchAcute myeloid leukemiaR/R acute myeloid leukemiaAcute myeloid leukemia casesComprehensive molecular testingAcute myeloid leukemia treatmentComprehensive mutational profilingTherapeutic decision-makingOncometabolite 2-hydroxyglutarateAberrant metabolic pathwaysTargeted treatment strategiesClinical practice guidelinesApoptosis of leukemia cellsNCCN guidelinesIDH1-mutantMyeloid leukemiaHeterogeneous malignancyGuideline updateMutation profilesTreatment strategiesMolecular testingTargeted treatmentGenetic mutationsIDH1 inhibitorsLeukemia cellsPractice guidelines
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply